News & Updates
Filter by Specialty:
COVID-19 shots temporarily mess up menstrual cycle length
Women who receive COVID-19 jabs may experience short-term changes in their menstrual cycle length, particularly those who have short, long, or irregular cycles prior to vaccination, a study has found.
COVID-19 shots temporarily mess up menstrual cycle length
29 Jul 2022BTX relieves endometriosis-associated chronic pelvic pain
The administration of onabotulinumtoxinA (BTX) led to relief of pain and spasm in premenopausal women with persistent pelvic pain due to endometriosis, a study presented at ESHRE 2022 has shown.
BTX relieves endometriosis-associated chronic pelvic pain
29 Jul 2022High-risk endometrial cancer outcomes not compromised with minimally invasive vs open surgery
In the treatment of endometrial cancer patients with high-risk histology, minimally invasive surgery neither worsens cancer prognosis nor contributes to a significant increase in the risks of recurrence and mortality as compared with open surgery, according to a systematic review and meta-analysis.
High-risk endometrial cancer outcomes not compromised with minimally invasive vs open surgery
27 Jul 2022Maternal vaccination reduces COVID-19 hospitalization risk in offspring
Full vaccination (two doses) with an mRNA COVID-19 vaccine during pregnancy was associated with a reduced risk of COVID-19-related hospitalization among infants younger than 6 months of age, according to a recent study.
Maternal vaccination reduces COVID-19 hospitalization risk in offspring
27 Jul 2022UltraVIOLET: Oteseconazole turns in satisfactory results for recurrent yeast infection
In the treatment and prevention of recurrent yeast infection or vulvovaginal candidiasis, oteseconazole performs similarly to standard-of-care fluconazole but better as compared with placebo, as shown in the results of the phase III ultraviolet study.
UltraVIOLET: Oteseconazole turns in satisfactory results for recurrent yeast infection
26 Jul 202220-µg hep B vaccine can prevent vertical transmission
Using a 20-µg dose to vaccinate children born to mothers with detectable levels of hepatitis B virus surface antigen (HBsAg) appears to avert vertical transmission, reports a recent China study.